Ignite Creation Date:
2025-12-24 @ 9:29 PM
Ignite Modification Date:
2025-12-25 @ 7:14 PM
Study NCT ID:
NCT04184232
Status:
COMPLETED
Last Update Posted:
2021-01-22
First Post:
2019-12-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Treatment of Recurrent Bladder Cancer With Dendritic Cells
Sponsor:
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Organization:
Study Overview
Official Title:
Treatment of Recurrent Bladder Cancer With Autologous Monocyte-derived Dendritic Cells
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Treatment of recurrent bladder cancer with dendritic cells
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: